eClinical Solutions has announced expanded artificial intelligence (AI) and machine learning (ML) capabilities within the elluminate IQ offering. Embedded in elluminate Data Central, the elluminate Clinical Data Cloud’s data management workbench provides access to trial data across systems and sources. elluminate IQ Review (eIQ Review) enables data management teams to utilize these AI/ML capabilities to conduct data review.
The elluminate platform including the expanded eIQ Review capabilities will be featured at industry events across the US and Europe this spring.
eClinical Solutions Expands elluminate IQ Offering for AI-Enabled Data Review to Deliver Increased Efficiencies and Quality to Clinical Data Management. (2023, May 24). Business Wire.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.